13.12.2017 • News

Clariant Wins China PDH Contract

The Catofin catalyst is used to produce olefins such as propylene or...
The Catofin catalyst is used to produce olefins such as propylene or isobutylene from light paraffin feedstocks. (c) twitter.com/clariant

Clariant and its US technology partner CB&I are developing a custom-built propane dehydrogenation (PDH) plant for China’s Xuzhou HaiDing Chemical Technology. The agreement includes a license and engineering design for a 600,000 t/y facility in Pizhou, Jiangsu province, China, based on Clariant’s Catofin catalyst and heat-generating material (HGM). A timescale for the project was not revealed.

The Catofin catalyst is used to produce olefins such as propylene or isobutylene from light paraffin feedstocks. HGM is a patented metal-oxide material loaded with the catalyst that increases the selectivity and yield of the Catofin units.

The contract follows another PDH project awarded to Clariant and CB&I in February this year by China’s Dongguan Grand Resource Science & Technology.

Globally, nine Catofin PDH units have been commissioned to date, producing more than 4.5 million t/y of propylene.

In separate news, the Swiss specialty chemicals producer is launching a 3D printing business to provide high-quality products for premium and customized printer filaments. The new business will support the fast-changing additive manufacturing technology, which supplies complex end-use products such as air ducts, drones, lights and parts for manufacturing equipment.

The Muttenz-based group said it will work closely with customers on polymer, additive and colorant selection to address typical end-use conditions such as weathering, flame retardancy and electrical properties.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.